463 related articles for article (PubMed ID: 28195186)
1. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
3. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
Ji WH; Jiang YH; Ji YL; Li B; Mao WM
Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
[TBL] [Abstract][Full Text] [Related]
4. Low cardiac dose and neutrophil-to-lymphocyte ratio predict overall survival in inoperable esophageal squamous cell cancer patients after chemoradiotherapy.
Ho YC; Lai YC; Lin HY; Ko MH; Wang SH; Yang SJ; Lin PJ; Chou TW; Hung LC; Huang CC; Chang TH; Lin JB; Lin JC
Sci Rep; 2021 Mar; 11(1):6644. PubMed ID: 33758232
[TBL] [Abstract][Full Text] [Related]
5. Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma.
Kijima T; Arigami T; Uchikado Y; Uenosono Y; Kita Y; Owaki T; Mori S; Kurahara H; Kijima Y; Okumura H; Maemura K; Ishigami S; Natsugoe S
Cancer Sci; 2017 Feb; 108(2):193-199. PubMed ID: 27889946
[TBL] [Abstract][Full Text] [Related]
6. [Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after radical resection of esophageal squamous cell carcinoma].
Chen H; He J
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):294-7. PubMed ID: 24989917
[TBL] [Abstract][Full Text] [Related]
7. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation.
He YF; Luo HQ; Wang W; Chen J; Yao YW; Yan Y; Wu SS; Hu XX; Ke LH; Niu JY; Li HM; Ji CS; Hu B
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26947428
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
Xie X; Luo KJ; Hu Y; Wang JY; Chen J
Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy.
Cox S; Hurt C; Grenader T; Mukherjee S; Bridgewater J; Crosby T
Radiother Oncol; 2017 Oct; 125(1):154-159. PubMed ID: 28893415
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil to lymphocyte ratio as prognostic indicator for patients with esophageal squamous cell cancer.
Gao GD; Sun B; Wang XB; Wang SM
Int J Biol Markers; 2017 Oct; 32(4):e409-e414. PubMed ID: 28799624
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil to Lymphocyte Ratio as Predictor of Treatment Response in Esophageal Squamous Cell Cancer.
Barbetta A; Nobel TB; Sihag S; Hsu M; Tan KS; Bains MS; Isbell JM; Janjigian YY; Wu AJ; Bott MJ; Jones DR; Molena D
Ann Thorac Surg; 2018 Sep; 106(3):864-871. PubMed ID: 29738752
[TBL] [Abstract][Full Text] [Related]
12. The Predictive Value of Pretreatment Neutrophil-To-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma.
Chen MF; Chen PT; Kuan FC; Chen WC
Ann Surg Oncol; 2019 Jan; 26(1):190-199. PubMed ID: 30362062
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
14. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma.
Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W
PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959
[TBL] [Abstract][Full Text] [Related]
15. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
16. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients.
Kosumi K; Baba Y; Ishimoto T; Harada K; Nakamura K; Ohuchi M; Kiyozumi Y; Izumi D; Tokunaga R; Taki K; Higashi T; Miyata T; Kurashige J; Hiyoshi Y; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Baba H
Surg Today; 2016 Apr; 46(4):405-13. PubMed ID: 26036223
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
19. Study on the predictive value of pretreatment peripheral blood inflammatory markers regarding immunotherapy in patients with inoperable advanced or locally advanced oesophageal squamous cell carcinoma.
Fu M; Li Z; Ma J; Shen F; Zhang X
Scand J Gastroenterol; 2024 Jun; 59(6):722-729. PubMed ID: 38362884
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]